StonvexLoading…
StonvexStonvexStonvexCore line items from FHTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $30.91M | $22.60M | $34.16M | $19.23M |
Operating Income | $-86.39M | $-102.68M | $-107.91M | $-117.14M |
Net Income | $-74.28M | $-86.62M | $-98.43M | $-108.88M |
EPS (Diluted) | $-1.18 | $-1.58 | $-2.34 | $-2.62 |
Total Assets | $198.10M | $283.98M | $285.92M | $404.88M |
Total Liabilities | $306.60M | $329.51M | $363.11M | $404.77M |
Cash & Equivalents | $80.88M | $55.45M | $80.34M | $52.21M |
Free Cash Flow OCF − CapEx | $-86.15M | $-101.31M | $-119.33M | $192.40M |
Shares Outstanding | 56.66M | 55.59M | 42.28M | 41.80M |